MarketCap
Facebook
X
Telegram
Exact Sciences Corporation Financial Ratios 2025-2011 | EXAS
Brief overview of Exact Sciences Corporation's valuation and returns
Ratios are assessed across five available annual reports in the 2021–2025 interval.
The current valuation set is P/S 6x (median 5.22x), P/B 8.12x (median 3.86x), P/CF 39.67x (median 57.93x). Current valuation broadly matches recent historical reference points; the difference from five-year medians is +14.9%.
End-period return metrics are ROE -8.7%, ROA -3.5%, ROCE -8.6%. Current return ratios are negative, materially weakening the fundamental profile.
The PEG ratio is 1.38x, reflecting a relatively balanced link between valuation and growth.
A shorter cycle, from 83.7 days to 42.5 days, indicates faster release of cash from operations.
Overall picture
Exact Sciences Corporation trades near its familiar ratio range. A new earnings or profitability trend is needed to change the view.
Annual Financial Ratios Exact Sciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-93.8 | -9.0 | -54.9 | -17.5 | -22.0 | -25.2 | -146.2 | -61.3 | -50.1 | -11.1 | -3.8 | -21.8 | -19.4 | -12.3 | -16.7 |
P/S |
6.0 | 3.4 | 4.5 | 5.2 | 7.4 | 13.9 | 14.0 | 23.6 | 21.5 | 18.6 | 15.3 | 1214.2 | 217.8 | 155.3 | 114.8 |
EPS |
-1.1 | -5.6 | -1.1 | -3.5 | -3.5 | -5.5 | -1.6 | -1.4 | -1.0 | -1.6 | -1.7 | -1.2 | -0.7 | -0.9 | -0.5 |
EV (Enterprise Value) |
22 B | 12.2 B | 13.9 B | 13.8 B | 16.1 B | 21.3 B | 13.3 B | 11.4 B | 5.73 B | 1.84 B | 602 M | 2.15 B | 901 M | 644 M | 456 M |
EBITDA per Share |
-0.43 | -5.04 | -0.56 | -2.8 | -4.44 | -4.62 | -1.66 | -1.12 | -0.888 | -1.54 | -1.68 | -1.23 | -0.671 | -0.869 | -0.541 |
EV/EBITDA |
-20.8 | -44.8 | -59.4 | -82.7 | -55.0 | -11.5 | -3.7 | -21.5 | -19.7 | -12.2 | -15.6 | ||||
PEG |
-0.8 | -0.05 | -2.58 | -0.41 | -0.53 | -0.62 | -2.65 | 1.38 | -1.27 | -2.37 | 0.1 | 0.27 | -0.9 | 0.19 | 0.19 |
P/B |
8.1 | 3.9 | 3.6 | 3.6 | 3.9 | 7.3 | 5.4 | 15.8 | 11.0 | 5.5 | 1.9 | 7.6 | 6.7 | 6.5 | 5.7 |
P/CF |
39.7 | 44.0 | 71.8 | -48.7 | -128.0 | 151.9 | -42.8 | -48.8 | -40.6 | -12.8 | -3.9 | -23.4 | -18.6 | -14.4 | -16.0 |
ROE % |
-8.66 | -42.83 | -6.49 | -20.49 | -17.58 | -36.84 | -3.67 | -25.72 | -21.98 | -49.87 | -48.28 | -34.62 | -34.37 | -53.21 | -34.34 |
ROA % |
-3.55 | -17.36 | -3.15 | -10.01 | -8.91 | -16.72 | -2.40 | -11.49 | -19.11 | -44.35 | -43.32 | -32.11 | -31.72 | -46.79 | -29.58 |
ROCE % |
-8.59 | -43.66 | -6.84 | -19.50 | -25.26 | -34.34 | -7.15 | -11.49 | -22.29 | -48.79 | -47.12 | -34.17 | -33.65 | -52.34 | -32.39 |
Current Ratio |
1.7 | 1.7 | 1.9 | 2.0 | 2.0 | 2.3 | 2.4 | 9.0 | 7.2 | 10.9 | 12.2 | 16.6 | 17.5 | 9.5 | 11.8 |
DSO |
30.8 | 29.9 | 26.4 | 32.8 | 46.5 | 44.5 | 54.4 | 35.5 | 36.3 | 31.3 | 45.7 | 279.3 | - | - | - |
DIO |
60.9 | 63.0 | 60.8 | 61.6 | 78.5 | 79.3 | 104.0 | 121.1 | 119.9 | 55.2 | 99.5 | 339.0 | - | - | - |
DPO |
49.2 | 36.6 | 38.0 | 39.4 | 41.2 | 31.8 | 43.7 | 87.0 | 74.4 | 5.7 | 49.3 | 223.4 | - | - | 11634.4 |
Operating Cycle |
91.7 | 92.9 | 87.2 | 94.4 | 124.9 | 123.8 | 158.4 | 156.6 | 156.2 | 86.5 | 145.1 | 618.3 | - | - | - |
Cash Conversion Cycle |
42.5 | 56.3 | 49.2 | 55.0 | 83.7 | 92.1 | 114.6 | 69.6 | 81.8 | 80.8 | 95.8 | 395.0 | - | - | -11634.4 |
All numbers in USD currency
Quarterly Financial Ratios Exact Sciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.1 | -0.01 | -0.54 | - | -0.21 | -0.09 | -0.6 | - | - | -0.45 | -0.42 | - | -0.84 | -0.94 | -1.04 | -1.28 | -0.97 | -1.03 | -0.18 | -2.67 | -1.35 | -0.45 | -0.91 | 0.56 | -0.31 | -0.3 | -0.66 | -0.44 | -0.37 | -0.3 | -0.33 | -0.18 | -0.23 | -0.27 | -0.32 | -0.34 | -0.36 | -0.46 | -0.49 | -0.41 | -0.45 | -0.44 | -0.4 | -0.38 | -0.39 | -0.24 | -0.23 | -0.17 | -0.16 | -0.19 | -0.17 | -0.22 | -0.21 | -0.26 | -0.19 | -0.18 | -0.15 | -0.13 | -0.08 |
EBITDA per Share |
0.03 | 0.15 | -0.35 | - | -0.05 | 0.02 | -0.42 | - | 0.2 | -0.27 | -0.28 | - | -0.64 | -0.76 | -0.88 | - | -0.81 | -0.88 | -1.65 | - | -1 | -0.22 | -0.45 | -0.59 | -0.11 | -0.16 | -0.49 | -0.4 | -0.22 | -0.2 | -0.27 | -0.19 | -0.23 | -0.28 | -0.32 | -0.35 | -0.36 | -0.46 | -0.47 | -0.42 | -0.46 | -0.44 | -0.39 | -0.38 | -0.36 | -0.22 | -0.22 | -0.17 | -0.15 | -0.18 | -0.17 | -0.22 | -0.2 | -0.25 | -0.19 | -0.19 | -0.14 | -0.12 | -0.08 |
ROE % |
-6.24 | -6.65 | -7.10 | -5.20 | -5.18 | -3.96 | -6.12 | -5.05 | -9.84 | -14.65 | -17.17 | -15.51 | -22.03 | -22.07 | -21.86 | -17.17 | -29.37 | -33.60 | -31.67 | -36.84 | -14.15 | -6.86 | -5.49 | -3.10 | -19.15 | -24.04 | -27.70 | -29.86 | -21.98 | -20.48 | -21.06 | -21.98 | -28.89 | -34.99 | -42.43 | -49.87 | -51.02 | -52.88 | -51.48 | -48.28 | -47.27 | -45.23 | -40.00 | -34.62 | -32.40 | -29.55 | -31.93 | -34.37 | -39.56 | -44.45 | -50.39 | -53.17 | -50.84 | -47.02 | -39.90 | -34.34 | -9.31 | -7.93 | -5.24 |
ROA % |
-2.69 | -2.93 | -3.14 | -2.53 | -2.52 | -1.94 | -2.98 | -2.44 | -4.80 | -7.17 | -8.68 | -7.93 | -11.23 | -8.60 | -11.23 | -8.90 | -14.10 | -15.70 | -14.45 | -16.72 | -6.00 | -3.05 | -2.76 | -2.40 | -8.16 | -9.98 | -11.27 | -11.49 | -11.59 | -13.10 | -15.86 | -19.11 | -25.33 | -30.87 | -37.60 | -44.35 | -45.48 | -47.25 | -46.11 | -43.35 | -42.73 | -41.19 | -36.67 | -31.98 | -29.92 | -27.28 | -29.47 | -31.72 | -35.89 | -39.83 | -44.66 | -46.75 | -44.49 | -40.96 | -34.56 | -29.58 | -8.02 | -6.83 | -4.51 |
ROCE % |
-6.34 | -6.55 | -7.28 | -5.46 | -5.24 | -3.79 | -5.48 | -4.82 | -9.26 | -13.92 | -16.38 | -14.85 | -19.53 | -19.78 | -19.63 | -17.75 | -26.84 | -31.25 | -29.42 | -15.78 | -20.69 | -13.15 | -11.64 | -10.93 | -17.04 | -21.49 | -24.81 | -27.20 | -20.59 | -20.04 | -21.28 | -22.73 | -29.56 | -35.52 | -42.95 | -50.41 | -51.53 | -53.35 | -51.93 | -48.67 | -47.57 | -45.48 | -40.21 | -34.79 | -32.58 | -29.75 | -32.10 | -34.56 | -39.73 | -44.62 | -50.59 | -53.39 | -51.05 | -47.25 | -40.10 | -34.52 | -9.39 | -7.95 | -5.27 |
Current Ratio |
1.7 | 1.7 | 1.7 | 1.7 | 1.9 | 1.9 | 2.0 | 1.9 | 1.9 | 1.9 | 1.9 | 2.0 | 2.0 | - | 2.0 | 2.0 | 2.1 | 2.1 | 2.2 | 1.8 | 1.8 | 1.8 | 1.8 | 2.9 | 2.9 | 2.9 | 2.9 | 1.8 | 1.8 | 1.8 | 1.8 | 7.7 | 7.7 | 7.7 | 7.7 | 9.0 | 9.0 | 9.0 | 9.0 | 9.8 | 9.8 | 9.8 | 9.8 | 13.1 | 13.1 | 13.1 | 13.1 | 13.0 | - | - | - | - | - | - | - | - | - | - | - |
DSO |
35.4 | 35.6 | 34.1 | - | 34.0 | 32.9 | 31.8 | - | 27.4 | 26.5 | 25.9 | - | 16.5 | 18.0 | 39.6 | 44.9 | 47.6 | 50.6 | 55.5 | 45.6 | 52.1 | 79.1 | 47.7 | 40.3 | 54.5 | 59.7 | 49.5 | 28.9 | 35.0 | 39.7 | 35.7 | 27.6 | 33.2 | 41.8 | 33.0 | - | - | - | - | - | 35.6 | 55.4 | 67.5 | - | 427.1 | 427.1 | 213.5 | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
57.5 | 63.9 | 75.0 | - | 55.5 | 55.4 | 61.1 | - | 71.4 | 74.1 | 70.5 | - | 35.4 | 35.6 | 73.8 | 76.7 | 72.9 | 71.6 | 75.2 | 84.4 | 88.6 | 108.1 | 86.1 | 80.0 | 107.6 | 110.1 | 107.5 | 94.4 | 120.3 | 134.5 | 131.7 | 101.1 | 114.6 | 132.0 | 88.3 | 45.0 | 51.2 | 61.8 | 68.0 | 79.5 | 80.9 | 119.6 | 115.8 | 107.8 | 396.7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
49.0 | 55.0 | 51.3 | - | 31.6 | 24.5 | 33.2 | - | 40.2 | 47.0 | 47.0 | - | 19.6 | 21.0 | 45.5 | 42.0 | 30.9 | 28.5 | 29.2 | 32.7 | 34.3 | 41.8 | 34.5 | 33.7 | 45.3 | 46.3 | 57.6 | 67.9 | 86.5 | 96.7 | 89.5 | 62.7 | 71.0 | 81.8 | 45.3 | 4.7 | 5.3 | 6.4 | 20.2 | 39.4 | 40.1 | 59.3 | 64.5 | 71.0 | 261.4 | - | - | - | - | - | - | - | - | - | - | 11634.4 | 11634.4 | 11634.4 | - |
Operating Cycle |
92.9 | 99.5 | 109.1 | - | 89.6 | 88.3 | 92.9 | - | 98.8 | 100.6 | 96.3 | - | 51.9 | 53.6 | 113.4 | 121.6 | 120.5 | 122.2 | 130.7 | 130.0 | 140.7 | 187.2 | 133.8 | 120.3 | 162.1 | 169.8 | 157.0 | 123.4 | 155.3 | 174.2 | 167.4 | 128.7 | 147.8 | 173.8 | 121.3 | 45.0 | 51.2 | 61.8 | 68.0 | 79.5 | 116.6 | 175.1 | 183.3 | 107.8 | 823.8 | 427.1 | 213.5 | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
43.9 | 44.5 | 57.9 | - | 57.9 | 63.7 | 59.6 | - | 58.6 | 53.6 | 49.3 | - | 32.3 | 32.6 | 67.9 | 79.6 | 89.7 | 93.7 | 101.5 | 97.4 | 106.4 | 145.4 | 99.3 | 86.6 | 116.8 | 123.5 | 99.4 | 55.5 | 68.8 | 77.5 | 77.9 | 66.0 | 76.8 | 92.0 | 76.0 | 40.3 | 45.9 | 55.3 | 47.8 | 40.1 | 76.5 | 115.8 | 118.8 | 36.8 | 562.4 | 427.1 | 213.5 | - | - | - | - | - | - | - | - | -11634.4 | -11634.4 | -11634.4 | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Exact Sciences Corporation, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
USA
Germany
Canada
Schweiz
Niderland
Britain
Israel
China
Australia
Irlanda
